Dr. Mark S. Kindy received his Ph.D. in Biochemistry from Boston University School of Medicine (1987), was a postdoctoral fellow at the Salk Institute (1987-89), and a faculty member at the University of Kentucky in the Department of Biochemistry (1989-2002) before moving to the Department of Neurosciences at MUSC in 2002. At the University of Kentucky, he held a number of administrative positions in research (Director of Programs) and on various Medical School and University committees. He previously was the Admiral Pihl Endowed Professor and former Director of the Neuroscience Institute in the Department of Neurosciences at MUSC. Dr. Kindy was a Career Research Scientist at the VA Medical Center and Director of the Phenomics Center (small animal imaging). Dr. Kindy recently served as the Assistant Provost for Research (Technology Transfer and Corporate Development) to assist with the transition of technology to small businesses and the Charleston Innovation Center. Dr. Kindy recently moved the University of South Florida, College of Pharmacy as Professor and Associate Dean for Research and Innovation. His major research interests are understanding the role of signal transduction pathways in stroke and spinal cord injury, the mechanisms of Abeta degradation and the role of the RAGE receptor in the interaction in the development and progression of Alzheimer’s disease and the development of therapeutic strategies for the treatment of neurodegenerative diseases. Dr. Kindy has served and serves on the editorial board of several journals, has served on the organizational committee for a number of meetings, has been invited to give numerous talks nationally and internationally on his research and currently serves on the Board of the Palmetto Chapter of the Alzheimer’s Association, the NOMD Study Section (previous chair) and has served on the AICS and AHA Brain I Study Sections and help in reviewing grants and manuscripts for various groups and journals. Dr. Kindy has published over 130 peer-reviewed articles in outstanding journals and has been funded by NIH, NSF, the VA, DoD, DARPA, and numerous foundations.